Innate Immune Responses in Chronic Obstructive Pulmonary Disease (COPD) Patients

NCT00826163 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Chronic Obstructive Pulmonary Disease

Interventions

DRUG: Budesonide

Sponsor

Mahidol University

Collaborators

[object Object]